Search clinical trials for: XP13512 (GSK1838262)
Total 21 results
-
XenoPort, Inc.GlaxoSmithKlineCompletedMigraine | Migraine DisordersUnited States, Canada
-
XenoPort, Inc.CompletedRestless Legs Syndrome
-
XenoPort, Inc.CompletedRestless Legs SyndromeUnited States
-
Astellas Pharma IncCompleted
-
XenoPort, Inc.CompletedRestless Legs SyndromeUnited States
-
XenoPort, Inc.CompletedRestless Legs Syndrome
-
XenoPort, Inc.CompletedRestless Legs SyndromeUnited States
-
XenoPort, Inc.CompletedRestless Legs Syndrome
-
XenoPort, Inc.CompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)United States
-
XenoPort, Inc.CompletedNeuralgia, PostherpeticUnited States, Germany
-
XenoPort, Inc.CompletedNeuralgia, PostherpeticUnited States, Canada
-
XenoPort, Inc.Completed
-
GlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
XenoPort, Inc.CompletedNeuropathy, DiabeticUnited States
-
XenoPort, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
XenoPort, Inc.Completed
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Canada
-
GlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
GlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States